Blueprint Medicines to Present at Upcoming Investor Conferences in June
05 Giugno 2015 - 2:30PM
PR Newswire (US)
CAMBRIDGE, Mass., June 5, 2015 /PRNewswire/ -- Blueprint
Medicines (NASDAQ: BPMC), a leader in discovering and developing
highly selective kinase drugs for genomically defined diseases,
today announced its participation in the following upcoming
investor conferences:
- Goldman Sachs 36th Annual Global Healthcare
Conference in Rancho Palos Verdes,
CA on Wednesday, June 10, 2015
at 4:00 p.m. PT (7:00 p.m. ET).
- JMP Securities Life Sciences Conference in New York, NY on Tuesday, June 23, 2015 at 11:00 a.m. ET.
Live webcasts of both events will be available by visiting the
Investors section of the Blueprint Medicines website at
www.blueprintmedicines.com. Archived replays of the webcast will be
available on the Company's website for 30 days after the
conference.
About Blueprint Medicines
Blueprint Medicines makes
kinase drugs to treat patients with genomically defined diseases.
Led by a team of industry innovators, Blueprint Medicines
integrates a novel target discovery engine and a proprietary
compound library to understand the blueprint of cancer and craft
highly selective therapies. This empowers the Blueprint Medicines
team to develop patient-defined medicines aimed at eradicating
cancer.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/blueprint-medicines-to-present-at-upcoming-investor-conferences-in-june-300094637.html
SOURCE Blueprint Medicines
Copyright 2015 PR Newswire
Grafico Azioni Blueprint Medicines (NASDAQ:BPMC)
Storico
Da Set 2024 a Ott 2024
Grafico Azioni Blueprint Medicines (NASDAQ:BPMC)
Storico
Da Ott 2023 a Ott 2024